Advances in the management of chronic renal failure: the use of epoetin alfa in clinical practice. Proceedings of a symposium. June 6, 1989, Nashville, TN.
出版信息
Pharmacotherapy. 1990 Mar-Apr;10(2 ( Pt 2)):1S-26S.
PMID:2345707
Abstract
摘要
相似文献
1
Advances in the management of chronic renal failure: the use of epoetin alfa in clinical practice. Proceedings of a symposium. June 6, 1989, Nashville, TN.
Pharmacotherapy. 1990 Mar-Apr;10(2 ( Pt 2)):1S-26S.
2
Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
Transplant Proc. 1991 Apr;23(2):1831-2.
3
Erythropoietin therapy in patients with chronic renal failure.
West J Med. 1992 Aug;157(2):154-7.
4
Management of the anaemia of chronic renal failure with recombinant erythropoietin.
Q J Med. 1989 Dec;73(272):1093-101.
5
Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
J Assoc Physicians India. 1991 Jun;39(6):483-5.
6
[Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
Med Clin (Barc). 1990 Nov 17;95(17):656-9.
7
[Treatment of renal anemia using synthetic human erythropoietin].
Ther Umsch. 1988 Dec;45(12):895-9.
8
Perspectives on the improvement of quality of life with epoetin alfa therapy.
Pharmacotherapy. 1990 Mar-Apr;10(2 ( Pt 2)):22S-26S.
9
Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life.
Semin Nephrol. 1989 Mar;9(1 Suppl 2):25-31.
10
Erythropoietin and chronic renal failure.
Nouv Rev Fr Hematol (1978). 1989;31(2):97-8.
Zotero 插件